Bergmann S.; Zheng D.; Barredo J.; Abboud M.R.; Jaffa A.A.
(PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2006)
Objective: Although improvements in the management of sickle cell disease (SCD) have increased patient survival into adulthood, morbidity and mortality from end-organ damage remain major concerns. One of the most serious ...